Published online Jul 15, 2026. doi: 10.4251/wjgo.v18.i7.118632
Revised: March 3, 2026
Accepted: April 7, 2026
Published online: July 15, 2026
Processing time: 160 Days and 0.8 Hours
Liver cancer is highly prevalent and fatal; transcatheter arterial chemoembo
To explore the application of process-based nursing using the Explain-Simulate-Practice-Communication-Support (ESPCS) model for pain management after interventional therapy for liver cancer.
A total of 500 patients who underwent interventional therapy for liver cancer and were admitted to Ganzhou Fifth People’s Hospital between January 2022 and January 2025 were selected and divided into a control group (n = 250, treated with routine nursing intervention) and an observation group (n = 250, treated with process-based nursing intervention using the ESPCS model) using a random num
At 2 hours, 6 hours, 12 hours, and 24 hours postoperatively, the Visual Analog Scale scores in the observation group were significantly lower than those in the control group (2 hours: 4.18 ± 0.85 vs 4.36 ± 1.03, P = 0.034; 6 hours: 3.31 ± 0.67 vs 3.69 ± 0.82, P < 0.001; 12 hours: 2.89 ± 0.58 vs 3.13 ± 0.65, P < 0.001; 24 hours: 1.82 ± 0.69 vs 2.51 ± 0.82, P < 0.001). After intervention, HADS-Anxiety and HADS-Depression scores were significantly lower in the ob
Process-based nursing interventions based on the ESPCS model can effectively alleviate the degree of pain in patients after interventional therapy for liver cancer, improve their psychological state and quality of life, and re
Core Tip: Process-based nursing based on the Explain-Simulate-Practice-Communication-Support model significantly reduced postoperative pain scores, alleviated anxiety and depression, improved quality of life, and lowered complication rates in patients undergoing transcatheter arterial chemoembolization for liver cancer. This model provides an evidence-based and structured nursing framework for postoperative pain management.
- Citation: Qian RH, Xu Y. Process-based nursing using explanation-simulation-practice-communication-support model for pain management after liver cancer intervention. World J Gastrointest Oncol 2026; 18(7): 118632
- URL: https://www.wjgnet.com/1948-5204/full/v18/i7/118632.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i7.118632
Control group: Routine nursing intervention was implemented, including: (1) Continuous monitoring of vital signs every 30 minutes within the first 2 hours after transcatheter arterial chemoembolization (TACE) and every 4 hours thereafter[1]; (2) Routine postoperative health education (approximately 15-20 minutes per session, once daily), covering basic disease knowledge and postoperative precautions[2]; (3) Standard pain assessment using the Visual Analog Scale (VAS) at 2 hours, 6 hours, 12 hours, and 24 hours postoperatively, with analgesics administered according to physicians’ orders when VAS ≥ 4[3]; (4) Dietary guidance according to medical advice; (5) Guidance on gradual mobilization beginning 6 hours postoperatively; and (6) Basic psychological support through bedside communication (10-15 minutes per day). The routine nursing intervention was continued until discharge[4,5].
The Explain-Simulate-Practice-Communication-Support (ESPCS) model is developed using the five-step teaching method proposed by Benner[6], an American scholar, in 2011, namely “Engage, Simulate, Practice, Confirm, and Sup
A total of 500 patients who underwent interventional therapy for liver cancer and were admitted to Ganzhou Fifth People's Hospital between January 2022 and January 2025 were selected and divided into two groups using a random number table method: The control group (n = 250, treated with routine nursing intervention) and the observation group (n = 250, treated with process-based nursing intervention using the ESPCS model). No statistically significant differences were observed in the general information between the two groups (P > 0.05), indicating comparability (Table 1). This study was approved by the Medical Ethics Committee of the Ganzhou Fifth People’s Hospital.
| General information | Control group (n = 250) | Observation group (n = 250) | χ2/t | P value |
| Gender | 0.298 | 0.585 | ||
| Male | 145 (58.00) | 151 (60.40) | ||
| Female | 105 (42.00) | 99 (39.60) | ||
| Lesion location | 0.457 | 0.496 | ||
| Left lobe | 72 (28.80) | 75 (30.00) | ||
| Right lobe | 125 (50.00) | 128 (51.20) | ||
| Bilobar | 53 (21.20) | 47 (18.80) | ||
| Number of lesions | 0.090 | 0.765 | ||
| Solitary | 182 (72.80) | 179 (71.60) | ||
| Multiple | 68 (27.20) | 71 (28.40) | ||
| Maximum lesion diameter | 0.130 | 0.719 | ||
| ≥ 5 cm | 138 (55.20) | 142 (56.80) | ||
| < 5 cm | 112 (44.80) | 108 (43.20) | ||
| Child-Pugh classification | 0.093 | 0.760 | ||
| Grade A | 64 (25.60) | 67 (26.80) | ||
| Grade B | 186 (74.40) | 183 (73.20) | ||
| Age (year), mean ± SD | 58.62 ± 6.37 | 58.33 ± 6.40 | 0.508 | 0.612 |
| BMI (kg/m2), mean ± SD | 22.56 ± 1.44 | 22.51 ± 1.48 | 0.383 | 0.702 |
| Number of interventional treatments, mean ± SD | 3.10 ± 0.86 | 3.06 ± 0.82 | 0.532 | 0.595 |
Inclusion criteria: (1) All patients met the clinical diagnostic criteria for liver cancer[9]; (2) All patients underwent TACE with a smooth surgical process; (3) Patients had good cognitive, verbal expression, reading and writing abilities; and (4) Informed consent was obtained from all patients, who were able to cooperate throughout the entire research process.
Exclusion criteria: (1) Patients with malignant tumors in other parts of the body; (2) Patients with an expected survival period of less than 3 months; (3) Patients with contraindications to TACE; (4) Patients with severe organic lesions of vital organs such as the heart and lungs; and (5) Patients with mental disorders who were unable to cooperate with the study.
Control group: Routine nursing intervention was implemented, which included routine vital sign monitoring after interventional therapy, explanation of disease-related knowledge to patients, and provision of psychological counseling. The patients’ diets were adjusted after the interventional therapy in accordance with the doctors’ advice. Patients were encouraged to get out of bed as early as possible and guided to perform the rehabilitation exercises.
Observation group: A process-based nursing intervention based on the ESPCS model was adopted, based on the routine nursing intervention applied in the control group, and the specific measures were as follows: (1) Explaining session: A relaxed and harmonious atmosphere was created. Nurses used the comprehensive assessment results of the patients’ disease data and physical conditions to conduct systematic health education through group lectures (including display boards, animations, and videos) and one-on-one interviews. The content covers the purpose of interventional therapy for liver cancer and the significance of postoperative pain management, daily healthcare, and precautions. After health education, the patients’ mastery of disease knowledge was evaluated using knowledge quizzes and verbal retelling. Positive feedback and encouragement were given to patients who answered fluently and mastered the knowledge proficiently, such as “your answer is excellent” and “we believe that with our joint efforts, a good rehabilitation effect will be achieved”, to enhance patients’ confidence in treatment. For patients who retold the content vaguely or had questions, nurses patiently answered their doubts, communicated closely with them to identify the causes of poor mastery, and provided reeducation on relevant knowledge; (2) Simulated session: Before performing functional training, patients were guided by nurses to watch videos to learn the methods and precautions for early rehabilitation functional training. In addition, patients and/or their family members were initially taught to recognize the pain rating scale and conduct self-assessment of pain. Subsequently, nurses demonstrated the content in the videos on-site, with each action demonstrated thrice, and the patients were encouraged to imitate. Nurses provided guidance throughout the process and answered the patients’ questions promptly during imitation, ensuring that all patients fully mastered the correct training methods and pain self-assessment skills; (3) Practice session: The operative limb was immobilized for 6 hours after interventional therapy, and the head of the bed was elevated by 15 degrees. The patients performed knee flexion exercises with the unaffected limb and ankle pump exercises with the operative limb under the guidance of nurses. According to the patients’ physical tolerance, they were assisted to perform rehabilitation training, including bed-chair transfer, out-of-bed sitting, standing, and walking, for 30 minutes per session and two sessions per day. Patients self-assessed their pain intensity at 2 hours, 4 hours, 6 hours, 12 hours, and 24 hours after surgery and actively reported the assessment results. Medical staff implemented pain management strategies combining non-pharmacological analgesic methods (chatting, listening to music, reading, guided imagery meditation, and mindfulness thinking) and pharmacological analgesia (in accordance with the doctors’ advice) based on the patients’ pain levels; (4) Communication session: Inductive communi
The above interventions were implemented until all patients were discharged from the hospital.
Pain score: The VAS[11] was used to assess pain intensity at 2 hours, 6 hours, 12 hours, and 24 hours after surgery. The scores range from 0 to 10, with higher scores indicating more severe pain.
Psychological status: The HADS[10] was applied to evaluate psychological status before and after intervention. The scale consists of two subscales: The HADS-Anxiety (HADS-A) and HADS-Depression (HADS-D), each with a score range of 0 to 21. Higher scores indicated more severe anxiety and depression. Cronbach’s α coefficients of the HADS-A and HADS-D subscales were 0.820 and 0.807, respectively.
Quality of life: The Functional Assessment of Cancer Therapy-General[12] was adopted to measure the quality of life before and after the intervention. The scale comprises four domains, including physical well-being, with 27 items. Each item is scored from 0 to 4, with higher total scores indicating better quality of life. Cronbach’s α coefficients for the physical well-being, social/family well-being, emotional well-being, and functional well-being domains of the scale were 0.884, 0.821, 0.867, and 0.835, respectively.
Incidence of complications: The occurrence of postoperative complications such as puncture site hematoma, infection, and dysuria/urinary retention was recorded for both groups.
All statistical data were analyzed using the SPSS 26.0 statistical software. Count data are expressed as n (%) and compared using the χ2 test. Measurement data conforming to a normal distribution are presented as mean ± SD and compared between groups using the independent samples t-test. Statistical significance was set at P < 0.05.
The VAS score at 24 hours postoperatively was markedly lower in the observation group (1.82 ± 0.69) compared with the control group (2.51 ± 0.82), with a statistically significant difference (t = 10.180, P < 0.001), indicating a clinically meaning
| Group | Case | 2 hours postoperatively | 6 hours postoperatively | 12 hours postoperatively | 24 hours postoperatively |
| Control | 250 | 4.36 ± 1.03 | 3.69 ± 0.82 | 3.13 ± 0.65 | 2.51 ± 0.82 |
| Observation | 250 | 4.18 ± 0.85 | 3.31 ± 0.67 | 2.89 ± 0.58 | 1.82 ± 0.69 |
| t | - | 2.131 | 5.674 | 4.356 | 10.180 |
| P value | - | 0.034 | < 0.001 | < 0.001 | < 0.001 |
Before intervention, there were no significant differences in HADS-A or HADS-D scores between the two groups (P > 0.05). After intervention, the HADS-A score was significantly lower in the observation group (7.15 ± 1.57) than in the control group (8.43 ± 1.82) (t = 8.420, P < 0.001), indicating more effective alleviation of anxiety symptoms. Similarly, the HADS-D score after intervention was lower in the observation group (6.72 ± 1.49) compared with the control group (7.26 ± 1.76), with a statistically significant difference (t = 3.703, P < 0.001), suggesting improved control of depressive symp
After intervention, the physical well-being score was significantly higher in the observation group (26.25 ± 3.01) than in the control group (24.40 ± 2.77) (t = 7.151, P < 0.001), reflecting improved physical status. The social/family well-being score was also higher in the observation group (18.33 ± 2.65 vs 16.06 ± 2.12; t = 10.576, P < 0.001), indicating enhanced social support perception. In terms of emotional well-being, the observation group scored 28.35 ± 3.43 compared with 25.70 ± 3.12 in the control group (t = 9.037, P < 0.001), demonstrating improved emotional adjustment. The functional well-being score was likewise significantly higher in the observation group (18.45 ± 3.03 vs 16.84 ± 2.86; t = 6.110, P < 0.001), indicating better recovery of daily functioning. Collectively, these results indicate that ESPCS-based nursing significantly enhanced multidimensional quality of life (Table 4).
| Group | Case | Physiological status | Social/family status | Emotional state | Function status | ||||
| Before | After | Before | After | Before | After | Before | After | ||
| Control | 250 | 14.05 ± 2.18 | 24.40 ± 2.77a | 10.53 ± 1.82 | 16.06 ± 2.12a | 13.61 ± 2.72 | 25.70 ± 3.12a | 12.61 ± 2.45 | 16.84 ± 2.86a |
| Observation | 250 | 14.03 ± 2.15 | 26.25 ± 3.01a | 10.49 ± 1.90 | 18.33 ± 2.65a | 13.65 ± 2.77 | 28.35 ± 3.43a | 12.74 ± 2.53 | 18.45 ± 3.03a |
| t | - | 0.103 | 7.151 | 0.240 | 10.576 | 0.163 | 9.037 | 0.584 | 6.110 |
| P value | - | 0.918 | < 0.001 | 0.810 | < 0.001 | 0.871 | < 0.001 | 0.560 | < 0.001 |
The total incidence of complications was significantly lower in the observation group (3.20%, 8/250) than in the control group (7.20%, 18/250), with a statistically significant difference (χ2 = 4.057, P = 0.044), suggesting improved safety and postoperative recovery. Specifically, puncture site hematoma occurred in 2.00% of patients in the observation group compared with 3.60% in the control group; infection occurred in 0.80% vs 2.00%; dysuria/urinary retention occurred in 0.40% vs 0.80%; and no cases of venous thrombosis were observed in the observation group. These findings indicate that process-based nursing based on the ESPCS model effectively reduced postoperative complications (Table 5).
| Group | Number of cases | Puncture site hematoma | Infection | Dysuria/urinary retention | Venous thrombosis | Total |
| Control group | 250 | 9 (3.60) | 5 (2.00) | 2 (0.80) | 2 (0.80) | 18 (7.20) |
| Observation group | 250 | 5 (2.00) | 2 (0.80) | 1 (0.40) | 0 (0.00) | 8 (3.20) |
| χ2 | - | - | - | - | - | 4.057 |
| P value | - | - | - | - | - | 0.044 |
TACE is currently the primary treatment modality for liver cancer, and its efficacy and safety have been widely validated in clinical practice[13-15]. However, with the advancement of clinical practice, several studies have found that TACE for liver cancer requires regular and repeated administration, which tends to induce several toxic side effects and seriously compromise patients’ quality of life[16,17]. Traditional clinical nursing focuses primarily on disease management and lacks multidimensional professional guidance in psychology, rehabilitation medicine, and other fields. Relatively, single content failed to yield optimal nursing outcomes. In contrast, process-based nursing, based on the ESPCS model, which is derived from medical simulation education, consists of five components: Explain, simulate, practice, communication, and support. It unleashes the advantages of combining theory with practice, emphasizes communication between medical staff and patients, and provides guidance and support in patient disease management. This model has been proven to play an important guiding role in improving patients’ self-care abilities and accelerating the rehabilitation process[18].
Previous studies have demonstrated that structured nursing interventions significantly improve postoperative recovery in patients undergoing TACE. Yu et al[18] reported that the ESPCS model improved self-management ability and postoperative tolerance in patients with colon cancer. Similarly, integrative psychological interventions recommended by the American Society of Clinical Oncology have been shown to reduce anxiety and depressive symptoms in cancer patients[19,20]. Consistent with these findings, the present study further confirms that the ESPCS-based nursing model can simultaneously improve pain control, psychological well-being, and quality of life in liver cancer patients receiving interventional therapy. Compared with conventional routine nursing, the structured and interactive nature of the ESPCS model may better address multidimensional patient needs.
Previous studies have demonstrated that psychological symptoms are prevalent among cancer patients, with anxiety and depression being the most common[20]. In particular, patients undergoing interventional therapy for liver cancer are more prone to negative psychological symptoms due to traumatic stress responses, fear of cancer recurrence, and other contributing factors[21,22]. Therefore, greater attention should be paid to patients’ psychological symptoms when strengthening disease management for these patients. Several international guidelines recommend mindfulness-based stress reduction, music therapy, and cognitive behavioral therapy as effective approaches for managing anxiety and depression in patients with cancer[23,24]. After the intervention, the HADS-A and HADS-D scores of the observation group were lower than those of the control group, and the Functional Assessment of Cancer Therapy-General scores were higher than those of the control group. This analysis suggests that the ESPCS-based nursing process fully embodies a patient-centered, holistic nursing concept. Patients can gain a comprehensive understanding of liver cancer-related management through different educational methods. Moreover, repeated communication and counseling, combined with psychological interventions, such as deep breathing training, music therapy, and mindfulness-based cognitive therapy, not only greatly boost patients’ confidence in rehabilitation but also provide effective channels for releasing negative emotions, thereby reducing the level of psychological stress response. Comprehensive interventions, including inspira
The literature reports that bed rest and immobilization after liver cancer interventional therapy increase the risk of complications, such as pressure injuries and urinary retention. Furthermore, because patients with cancer are often in a hypercoagulable state, the incidence of venous thrombosis increases with a prolonged duration of postoperative immobilization[25]. The results of this study demonstrated that the incidence of complications was lower in the observation group than in the control group (3.20% vs 7.20%). Multifaceted nursing interventions, including explain, communication, and support sessions under the ESPCS-based process nursing model, can alleviate patients’ psychological and physiological stress responses, enabling them to maintain a positive mental state and reduce the immunosuppressive effect of tumors. Enhanced pain assessment and management can reduce postoperative stress responses, significantly improve physiolo
However, several limitations should be acknowledged. First, this was a single-center study, which may limit the generalizability of the findings. Second, although randomization was performed, blinding was not implemented due to the nature of the nursing intervention, which may introduce potential performance bias. Third, the follow-up period was limited to hospitalization, and long-term outcomes such as chronic pain, recurrence-related anxiety, and sustained quality-of-life improvements were not evaluated. In addition, potential confounding factors such as socioeconomic status and family support level were not quantitatively analyzed. Future multicenter randomized controlled trials with long-term follow-up are needed to further validate these findings and explore the sustainability of the ESPCS nursing model.
In conclusion, process-based nursing interventions based on the ESPCS model can effectively alleviate postoperative pain, improve the psychological status and quality of life, and reduce the incidence of complications in patients under
| 1. | Li Q, Xia C, Li H, Yan X, Yang F, Cao M, Zhang S, Teng Y, He S, Cao M, Chen W. Disparities in 36 cancers across 185 countries: secondary analysis of global cancer statistics. Front Med. 2024;18:911-920. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 62] [Reference Citation Analysis (1)] |
| 2. | Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, Li L, Wei W, He J. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4:47-53. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 1395] [Cited by in RCA: 1526] [Article Influence: 763.0] [Reference Citation Analysis (5)] |
| 3. | Xu L, Chen S, Cao H, Feng Z, Yang C. Efficacy of sorafenib plus transcatheter arterial chemoembolization in treating hepatocellular carcinoma with portal vein tumor thrombosis: A meta-analysis. Acta Pharm. 2024;74:405-422. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 5] [Reference Citation Analysis (0)] |
| 4. | Liu XJ, Song PW, Wang LG, Zou HN, Zhang LL. Meta-Analysis on the Therapeutic Effect of Transcatheter Arterial Chemoembolization Combined with Portal Vein Embolization. Chemotherapy. 2024;69:212-223. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 1] [Reference Citation Analysis (0)] |
| 5. | Feng J, Zhao Y, Zhai L, Zhou J. Efficacy and safety of transarterial chemoembolization combined with targeted therapy and immunotherapy versus with targeted monotherapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis. Medicine (Baltimore). 2024;103:e38037. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 8] [Cited by in RCA: 11] [Article Influence: 5.5] [Reference Citation Analysis (1)] |
| 6. | Benner P. Educating nurses: a call for radical transformation-how far have we come? J Nurs Educ. 2012;51:183-184. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 81] [Cited by in RCA: 93] [Article Influence: 6.6] [Reference Citation Analysis (0)] |
| 7. | Wen J, Gheisari M. iVisit-Communicatefor AEC Education: Using Virtual Humans to Practice Communication Skills in 360-Degree Virtual Field Trips. J Comput Civ Eng. 2023;37:04023008. [DOI] [Full Text] |
| 8. | Soto-Perez-de-Celis E, Ke Y, Tanay M, Dagsi M, Bergerot C, Dixit N, Eng L, Cardeña-Gutiérrez A, Jiang C, Velazquez AI, Islami F, Chan A. Equity, diversity, and inclusion in the Multinational Association for Supportive Care in Cancer: a global membership survey. Support Care Cancer. 2024;32:205. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 1] [Reference Citation Analysis (0)] |
| 9. | Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, Roberts LR, Heimbach JK. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68:723-750. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 3837] [Cited by in RCA: 3541] [Article Influence: 442.6] [Reference Citation Analysis (7)] |
| 10. | Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-370. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 36742] [Cited by in RCA: 32483] [Article Influence: 755.4] [Reference Citation Analysis (4)] |
| 11. | Bielewicz J, Daniluk B, Kamieniak P. VAS and NRS, Same or Different? Pain Res Manag. 2022;2022:5337483. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 1] [Cited by in RCA: 78] [Article Influence: 19.5] [Reference Citation Analysis (0)] |
| 12. | Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570-579. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 4926] [Cited by in RCA: 4407] [Article Influence: 133.5] [Reference Citation Analysis (0)] |
| 13. | Xu C, Su R, Lu Z, Song Y, Zhang X, Shu W, Yang Z, Zhuang R, Xu X, Wei X. Heterogeneity of hepatocellular carcinoma that responds differently to combination therapy with TACE and Sorafenib as determined by digital spatial gene expression profiling. Genes Genomics. 2024;46:1045-1058. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 3] [Reference Citation Analysis (0)] |
| 14. | Yoshitomi K, Hayashi T, Oe S, Shibata M, Honma Y, Harada M, Kooka Y. Child-Pugh grade deterioration stratified by the etiology after transcatheter arterial chemoembolization as initial treatment for hepatocellular carcinoma. Sci Rep. 2024;14:3707. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 10] [Reference Citation Analysis (0)] |
| 15. | Duan X, Li H, Chen P, Sun T, Kuang D, Lu H, Qiao B, Fan Z, Ren Z, Han X. Transcatheter arterial chemoembolization using CalliSpheres beads loaded with arsenic trioxide for unresectable large or huge hepatocellular carcinoma: a prospective study. Eur Radiol. 2024;34:1258-1267. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 5] [Cited by in RCA: 7] [Article Influence: 3.5] [Reference Citation Analysis (1)] |
| 16. | Lu H, Liang B, Xia X, Zheng C. Predictors and risk factors of bile duct injury after transcatheter arterial chemoembolization for hepatocellular carcinoma. BMC Cancer. 2024;24:1085. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 8] [Cited by in RCA: 11] [Article Influence: 5.5] [Reference Citation Analysis (0)] |
| 17. | Kelliher LJS, Scott M. Modifying the Stress Response - Perioperative Considerations and Controversies. Anesthesiol Clin. 2022;40:23-33. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 2] [Cited by in RCA: 14] [Article Influence: 3.5] [Reference Citation Analysis (0)] |
| 18. | Yu R, Sun M, Xia S, Zhang L. Effects of ESPCS mode nursing on the surgical tolerance, gastrointestinal tract recovery and selfmanagement efficacy of patients with colon cancer. Oncol Lett. 2024;27:247. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 2] [Cited by in RCA: 3] [Article Influence: 1.5] [Reference Citation Analysis (0)] |
| 19. | van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis. J Pain Symptom Manage. 2016;51:1070-1090.e9. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1365] [Cited by in RCA: 1119] [Article Influence: 111.9] [Reference Citation Analysis (0)] |
| 20. | Riedl D, Schuessler G. Prevalence of Depression and Cancer - A systematic review. Z Psychosom Med Psychother. 2022;68:74-86. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1] [Cited by in RCA: 26] [Article Influence: 5.2] [Reference Citation Analysis (0)] |
| 21. | Christodoulidis G, Konstantinos-Eleftherios K, Marina-Nektaria K. Double role of depression in gastric cancer: As a causative factor and as consequence. World J Gastroenterol. 2024;30:1266-1269. [PubMed] [DOI] [Full Text] |
| 22. | Huang J, Xu T, Dai Y, Li Y, Tu R. Age-related differences in the number of chronic diseases in association with trajectories of depressive symptoms: a population-based cohort study. BMC Public Health. 2024;24:2496. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 19] [Cited by in RCA: 22] [Article Influence: 11.0] [Reference Citation Analysis (0)] |
| 23. | Andersen BL, Lacchetti C, Ashing K, Berek JS, Berman BS, Bolte S, Dizon DS, Given B, Nekhlyudov L, Pirl W, Stanton AL, Rowland JH. Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update. J Clin Oncol. 2023;41:3426-3453. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 220] [Cited by in RCA: 195] [Article Influence: 65.0] [Reference Citation Analysis (0)] |
| 24. | Carlson LE, Ismaila N, Addington EL, Asher GN, Atreya C, Balneaves LG, Bradt J, Fuller-Shavel N, Goodman J, Hoffman CJ, Huston A, Mehta A, Paller CJ, Richardson K, Seely D, Siwik CJ, Temel JS, Rowland JH. Integrative Oncology Care of Symptoms of Anxiety and Depression in Adults With Cancer: Society for Integrative Oncology-ASCO Guideline. J Clin Oncol. 2023;41:4562-4591. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 201] [Cited by in RCA: 153] [Article Influence: 51.0] [Reference Citation Analysis (0)] |
| 25. | Ngo D, Chen J, Nguyen C, Choi K, Pullarkat V. Patterns of interventions for central venous catheter-associated deep vein thrombosis and outcomes in cancer patients. J Oncol Pharm Pract. 2025;31:12-16. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1] [Cited by in RCA: 3] [Article Influence: 3.0] [Reference Citation Analysis (0)] |